| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndromes
|
Platzbecker, Uwe
|
|
2012
|
49 |
4 |
p. 342-349
8 p.
|
article
|
| 2 |
Clinical Results With the DNA Hypomethylating Agent 5-Aza-2′-Deoxycytidine (Decitabine) in Patients With Myelodysplastic Syndromes: An Update
|
Joeckel, Tina E.
|
|
2012
|
49 |
4 |
p. 330-341
12 p.
|
article
|
| 3 |
Cover
|
|
|
2012
|
49 |
4 |
p. OFC-
1 p.
|
article
|
| 4 |
Erratum
|
|
|
2012
|
49 |
4 |
p. 361-
1 p.
|
article
|
| 5 |
Erratum
|
|
|
2012
|
49 |
4 |
p. 361-
1 p.
|
article
|
| 6 |
Future Issues and Recent Issues
|
|
|
2012
|
49 |
4 |
p. A3-
1 p.
|
article
|
| 7 |
Immunomodulatory Treatment of Myelodysplastic Syndromes: Antithymocyte Globulin, Cyclosporine, and Alemtuzumab
|
Parikh, Ankur R.
|
|
2012
|
49 |
4 |
p. 304-311
8 p.
|
article
|
| 8 |
Introduction: Application of New Therapies to Myelodysplastic Syndrome
|
Giagounidis, Aristoteles
|
|
2012
|
49 |
4 |
p. 285-286
2 p.
|
article
|
| 9 |
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes
|
Giagounidis, Aristoteles A.N.
|
|
2012
|
49 |
4 |
p. 312-322
11 p.
|
article
|
| 10 |
Masthead
|
|
|
2012
|
49 |
4 |
p. IFC-
1 p.
|
article
|
| 11 |
Overview of Myelodysplastic Syndromes
|
Beris, Photis
|
|
2012
|
49 |
4 |
p. 287-294
8 p.
|
article
|
| 12 |
Previous Issues
|
|
|
2012
|
49 |
4 |
p. A2-
1 p.
|
article
|
| 13 |
Table of Contents
|
|
|
2012
|
49 |
4 |
p. A1-
1 p.
|
article
|
| 14 |
The Non-transplant Treatment of Myelodysplastic Syndromes—What's on the Horizon?
|
Kulasekararaj, Austin G.
|
|
2012
|
49 |
4 |
p. 350-360
11 p.
|
article
|
| 15 |
Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
|
Adès, Lionel
|
|
2012
|
49 |
4 |
p. 323-329
7 p.
|
article
|
| 16 |
Treatment of Low-Risk Myelodysplastic Syndrome: Hematopoietic Growth Factors Erythropoietins and Thrombopoietins
|
Santini, Valeria
|
|
2012
|
49 |
4 |
p. 295-303
9 p.
|
article
|
Journal description